{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:29:36Z","timestamp":1795058976025,"version":"4.10.2"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2018-03462"],"award-info":[{"award-number":["PICT 2018-03462"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.actatropica.2022.106334","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T08:34:27Z","timestamp":1643445267000},"page":"106334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection"],"prefix":"10.1016","volume":"229","author":[{"given":"Estefan\u00eda","family":"Prochetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Bontempi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Rodeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Vicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Cacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Florencia","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"P\u00e9rez Gianeselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rosa","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Marcipar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2022.106334_bib0001","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/315743","article-title":"Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago","volume":"182","author":"Bahia-Oliveira","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106334_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007413","article-title":"A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection","volume":"13","author":"Barry","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2022.106334_bib0003","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jphp.12768","article-title":"Development and assessment of a new cage-like particle adjuvant","volume":"69","author":"Bertona","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0004","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/imt-2017-0009","article-title":"Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi","volume":"9","author":"Bontempi","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.actatropica.2022.106334_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13469","article-title":"Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection","author":"Bontempi","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0006","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.vaccine.2015.01.044","article-title":"Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental chagas disease","volume":"33","author":"Bontempi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106334_bib0007","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm1744","article-title":"Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease","volume":"14","author":"Bustamante","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.actatropica.2022.106334_bib0008","doi-asserted-by":"crossref","first-page":"eabb7656","DOI":"10.1126\/scitranslmed.abb7656","article-title":"A modified drug regimen clears active and dormant trypanosomes in mouse models of chagas disease","volume":"12","author":"Bustamante","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actatropica.2022.106334_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165692","article-title":"Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-sialidase rides the show","volume":"1866","author":"Campetella","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.actatropica.2022.106334_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.565142","article-title":"Cruzipain and its physiological inhibitor, chagasin, as a DNA-based therapeutic vaccine against Trypanosoma cruzi","volume":"11","author":"Cerny","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0011","first-page":"1","article-title":"Oxidative stress implications for therapeutic vaccine development against chagas disease","author":"Choudhuri","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.actatropica.2022.106334_bib0012","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40264-018-0696-5","article-title":"Safety profile of benznidazole in the treatment of chronic chagas disease: experience of a referral centre and systematic literature review with meta-analysis","volume":"41","author":"Crespillo-And\u00fajar","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.actatropica.2022.106334_bib0013","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1038\/s41598-021-82930-w","article-title":"Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection","volume":"11","author":"Cruz-Chan","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2022.106334_bib0014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(03)00093-8","article-title":"Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR","volume":"129","author":"Cummings","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0015","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1371\/journal.pntd.0000419","article-title":"Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients","volume":"3","author":"Duffy","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2022.106334_bib0016","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/erv.12.85","article-title":"Accelerating the development of a therapeutic vaccine for human chagas disease: rationale and prospects","volume":"11","author":"Dumonteil","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.actatropica.2022.106334_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/IAI.72.1.46-53.2004","article-title":"Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice","volume":"72","author":"Dumonteil","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2022.106334_bib0018","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1645\/GE-2396.1","article-title":"ECG detection of murine chagasic cardiomyopathy","volume":"96","author":"Eickhoff","year":"2010","journal-title":"J. Parasitol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0019","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.vaccine.2008.02.060","article-title":"Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate","volume":"26","author":"Fontanella","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106334_bib0020","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.1038\/srep35351","article-title":"Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage","volume":"6","author":"Francisco","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2022.106334_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00832-18","article-title":"Assessing the effectiveness of curative benznidazole treatment in preventing chronic cardiac pathology in experimental models of chagas disease","volume":"62","author":"Francisco","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2022.106334_bib0022","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1017\/S0031182000075703","article-title":"Trans-sialidase, SAPA amino acid repeats and the relationship between Trypanosoma cruzi and the mammalian host","volume":"108","author":"Frasch","year":"1994","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2022.106334_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.671104","article-title":"Targeting myeloid-derived suppressor cells to enhance a trans-sialidase-based vaccine against Trypanosoma cruzi","volume":"11","author":"Gamba","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0024","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with benznidazole during the chronic phase of experimental chagas\u2019 disease decreases cardiac alterations","volume":"49","author":"Garcia","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2022.106334_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.exppara.2010.05.010","article-title":"Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs","volume":"126","author":"Grosso","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130562","article-title":"Therapeutic efficacy of a subunit vaccine in controlling chronic Trypanosoma cruzi infection and chagas disease is enhanced by glutathione peroxidase over-expression","volume":"10","author":"Gupta","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2022.106334_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00876-17","article-title":"Vaccine-linked chemotherapy improves benznidazole efficacy for acute chagas disease","volume":"86","author":"Jones","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2022.106334_bib0028","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2017.03.011","article-title":"Therapeutic vaccination for chronic hepatitis B","volume":"23","author":"Kosinska","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0029","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1086\/648072","article-title":"Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy","volume":"49","author":"Laucella","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106334_bib0030","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1016\/j.vaccine.2010.08.104","article-title":"Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells","volume":"28","author":"Limon-Flores","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2022.106334_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007717","article-title":"Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection","volume":"14","author":"Mann","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2022.106334_bib0032","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/IAI.72.4.2350-2357.2004","article-title":"Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of chagas\u2019 disease","volume":"72","author":"Marinho","year":"2004","journal-title":"IAI"},{"key":"10.1016\/j.actatropica.2022.106334_bib0033","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.micinf.2009.07.011","article-title":"Infection by the sylvio X10\/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of chagas\u2019 disease","volume":"11","author":"Marinho","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2022.106334_bib0034","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.micinf.2008.07.027","article-title":"Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of paracoccidioides brasiliensis","volume":"10","author":"Marques","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2022.106334_bib0035","first-page":"196","article-title":"Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia","volume":"32","author":"Mej\u00eda-Jaramillo","year":"2012","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.actatropica.2022.106334_bib0036","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1128\/AAC.42.10.2549","article-title":"Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi","volume":"42","author":"Michailowsky","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2022.106334_bib0037","doi-asserted-by":"crossref","first-page":"H747","DOI":"10.1152\/ajpheart.1998.274.3.H747","article-title":"Measurement of heart rate and Q-T interval in the conscious mouse","volume":"274","author":"Mitchell","year":"1998","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0038","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic chagas\u2019 cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2022.106334_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004594","article-title":"A human Type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy","volume":"11","author":"Pereira","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.actatropica.2022.106334_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0035-9203(86)90193-8","article-title":"A histopathological analysis of the course of myocarditis in C3H\/He mice infected with Trypanosoma cruzi clone sylvio-X10\/4","volume":"80","author":"Postan","year":"1986","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2022.106334_bib0041","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0035-9203(86)90166-5","article-title":"Trypanosoma cruzi: constancy of clone pathogenicity for inbred mice during long-term in vitro maintenance","volume":"80","author":"Postan","year":"1986","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2022.106334_bib0042","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.18217","article-title":"Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory\/suppressor phenotype","volume":"8","author":"Prochetto","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.actatropica.2022.106334_bib0043","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1590\/0074-02760160334","article-title":"Chronic chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole evaluation for interrupting trypanosomiasis (BENEFIT) trial","volume":"112","author":"Rassi","year":"2017","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2022.106334_bib0044","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0031182018001567","article-title":"Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection","volume":"146","author":"Rial","year":"2019","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2022.106334_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/342415","article-title":"Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure","volume":"186","author":"Romanha","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2022.106334_bib0046","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0074-02762010000200022","article-title":"In vitro and in vivo experimental models for drug screening and development for chagas disease","volume":"105","author":"Romanha","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2022.106334_bib0047","doi-asserted-by":"crossref","first-page":"e34039","DOI":"10.7554\/eLife.34039","article-title":"Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure","volume":"7","author":"S\u00e1nchez-Vald\u00e9z","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.actatropica.2022.106334_bib0048","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1038\/s41598-017-08086-8","article-title":"A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses","volume":"7","author":"Santi-Rocca","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actatropica.2022.106334_bib0049","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.47.1.223-230.2003","article-title":"Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes","volume":"47","author":"Toledo de","year":"2003","journal-title":"AAC"},{"key":"10.1016\/j.actatropica.2022.106334_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives","volume":"62","author":"Urbina","year":"2015","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.actatropica.2022.106334_bib0052","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.imlet.2005.11.015","article-title":"Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice","volume":"103","author":"Zapata-Estrella","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.actatropica.2022.106334_bib0053","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actatropica.2017.09.017","article-title":"Trypanosoma cruzi genetic diversity: something new for something known about chagas disease manifestations, serodiagnosis and drug sensitivity","volume":"184","author":"Zingales","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2022.106334_bib0054","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","article-title":"A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI","volume":"104","author":"Zingales","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2022.106334_bib0051","unstructured":"World Health Organization, 2020. Chagas disease (also known as American trypanosomiasis) [WWW Document]. URL https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis) (accessed 5.21.21)."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X2200033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X2200033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:24:37Z","timestamp":1762075477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X2200033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":54,"alternative-id":["S0001706X2200033X"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2022.106334","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2022.106334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106334"}}